Bevacizumab chemotherapy for management of pulmonary and laryngotracheal papillomatosis in a child-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bevacizumab chemotherapy for management of pulmonary and laryngotracheal papillomatosis in a child

Published:2016-12-20 Issue:7 Volume:127 Page:1538-1542
ISSN:0023-852X
Container-title:The Laryngoscope
language:en
Short-container-title:The Laryngoscope

Author:

Zur Karen B.¹²,Fox Elizabeth³

Affiliation:

1. Division of Pediatric Otolaryngology; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania U.S.A.

2. Department of Otolaryngology: Head and Neck Surgery, Perelman School of Medicine; The University of Pennsylvania; Philadelphia Pennsylvania U.S.A.

3. Division of Oncology; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania U.S.A.

Publisher

Wiley

Subject

Otorhinolaryngology

Reference13 articles.

1. The VEGF Family in cancer and antibody-based strategies for their inhibition;Sullivan;MAbs,2010

2. Rapid response to systemic Bevacizumab therapy in recurrent respiratory papillomatosis;Mohr;Oncol Lett,2014

3. Phase I trial and pharmacokinetic study of Bevacizumab in pediatric patients with refractory solid tumors: a children's oncology group study;Glade Bender;J Clin Oncol,2008

4. American Society of Pediatric Otolaryngology Members' experience with recurrent respiratory papillomatosis and the use of adjuvant therapy;Schraff;Arch Otolaryngol Head Neck Surg,2004

5. Recurrent respiratory papillomatosis: current and future perspectives;Carifi;Ther Clin Risk Manag,2015

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Juvenile onset recurrent respiratory papillomatosis: What do we know in 2024 ?;Tumour Virus Research;2024-06

2. Healthcare Spending and Systemic Bevacizumab for Recurrent Respiratory Papillomatosis;Journal of Voice;2024-04

3. Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement;The Laryngoscope;2023-07-20

4. Aggressive recurrent respiratory papillomatosis: A series of five consecutive patients successfully treated with adjuvant intravenous bevacizumab. A single Belgian academic center experience;Head & Neck;2023-02-25

5. Long‐Term Follow‐up of Parenteral Bevacizumab In Patients with Recurrent Respiratory Papillomatosis;The Laryngoscope;2023-02-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3